Jan 13, 2025 06:34AM
Jan 13, 2025 06:30AM
Jan 13, 2025 06:30AM
Nov 12, 2024 06:30AM
Nov 11, 2024 07:00AM
Nov 11, 2024 06:30AM
Sep 3, 2024 04:58AM Goldman Sachs Reiterates Buy Rating on Spring Works Therapeutics (SWTX)
Aug 29, 2024 08:16AM
Aug 28, 2024 06:31AM
Aug 28, 2024 06:30AM
Nov 2, 2023 06:30AM
Nov 1, 2023 06:30AM
Aug 2, 2023 06:30AM
Jun 5, 2023 06:30AM SpringWorks Therapeutics Inc. (SWTX) Announces PDUFA Date Extension for Nirogacestat NDA
Jun 5, 2023 06:30AM
Jun 5, 2023 06:30AM
May 30, 2023 06:42AM
May 30, 2023 06:30AM
May 25, 2023 05:06PM
May 25, 2023 05:05PM
May 11, 2023 12:17PM SpringWorks Therapeutics (SWTX) Announces Clinical Data Presentations of Nirogacestat in Combination with BCMA-Directed Therapies at EHA
May 11, 2023 12:14PM
May 3, 2023 06:30AM
Mar 8, 2023 05:05PM
Mar 8, 2023 05:05PM
Feb 28, 2023 06:30AM
Feb 28, 2023 06:30AM
Feb 27, 2023 06:30AM SpringWorks Therapeutics (SWTX) Announces FDA Acceptance and Priority Review of NDA for Nirogacestat
Feb 27, 2023 06:30AM
Feb 27, 2023 06:30AM

15,423 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All